Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified-release versus standard tacrolimus in heart transplant recipients
2016-002097-13Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jul 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Tacrolimus C0 concentration variability. Started Jul 2016; status: completed.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on 2016-002097-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002097-13.